Nimotuzumab plus platinum-based chemotherapy versus platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma

BACKGROUND: Palliative chemotherapy has been the mainstay treatment for patients with recurrent or metastatic nasopharyngeal carcinoma (R/M-NPC). However, little is known about the efficacy and toxicity of nimotuzumab (NTZ) – a monoclonal antibody drug targeting epidermal growth factor receptor – pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yunshu, Yang, Sheng, Zhou, Shengyu, Yang, Jianliang, Qin, Yan, Gui, Lin, Shi, Yuankai, He, Xiaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498835/
https://www.ncbi.nlm.nih.gov/pubmed/32973932
http://dx.doi.org/10.1177/1758835920953738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498835/
https://www.ncbi.nlm.nih.gov/pubmed/32973932
http://dx.doi.org/10.1177/1758835920953738

Ejemplares similares